 BOTHELL, Wash., March 22, 2021 PRNewswire -- BioLife Solutions , Inc. NASDAQ: BLFS BioLife or the Company, a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced financial results for the fourth quarter and year ended December 31, 2020. 